Stephen Spurgeon

School of Medicine, Hematology & Medical Oncology

Publications

• 1.

  2013

  Stephen E. Spurgeon; Greg Coffey; Luke B. Fletcher; Russell Burke; Jeffrey W. Tyner; Brian J. Druker; Andreas Betz; Francis DeGuzman; Yvonne Pak; Dale Baker; et al.

  The selective syk inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemias

  Journal of Pharmacology and Experimental Therapeutics. 2013;344(2):378-387.

• 2.

  2013

  Jeffrey W. Tyner; Wayne F. Yang; Armand Bankhead III; Guang Fan; Luke B. Fletcher; Jade Bryant; Jason M. Glover; Bill H. Chang; Stephen E. Spurgeon; William H. Fleming; et al.

  Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening

  Cancer Research. 2013;73(1):285-296.

• 3.

  2012

  Rekha Chandran; Stuart K. Gardiner; Miklos Simon; Stephen E. Spurgeon

  Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007

  Leukemia and Lymphoma. 2012;53(8):1488-1493.

Journals

•  
  Publications
• Leukemia and Lymphoma
  2
• Urology
  1
• Cancer Research
  1
• Expert Opinion on Investigational Drugs
  1
• Journal of Oncology Pharmacy Practice
  1

Institutional Network

• Internal Organizations
  Shared Pub.
• Public Health & Preventive Medicine
  3

  
• Pathology
  2

  
• Pediatrics
  1

  

• External Organizations
  Shared Pub.
• VA Medical Center
  2
• Devers Eye Institute
  1
• Washington University in St. Louis School of Medicine
  1
• University of Utah School of Medicine
  1
• Penn State College of Medicine
  1
• Myriad Genetics, Inc.
  1

Coauthor Network

• Internal Coauthors
  Shared Pub.
• Tomasz (Tom) Beer
  2

  
• Brian Druker
  2

  
• Marc Loriaux
  2

  
• Motomi (Tomi) Mori
  2

  
• Jeffrey Tyner
  2

  
• Bill Chang
  1

  

• External Coauthors
  Shared Pub.
• Mark Garzotto
  2
• Elliot M Epner
  2
• Stuart K Gardiner
  1
• Luke B Fletcher
  1
• Adrianna Rivadinera
  1
• John D Phillips
  1